Today: 4 April 2026
Subscribe
Browse Category

Stock Market 6 November 2025

Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

Vistra reported Q3 GAAP net income of $652 million and revenue of $4.97 billion, down 21% year over year. The board approved an extra $1 billion in share repurchases through 2027. The company completed 2.6 GW in gas plant acquisitions and signed a 20-year, 1,200-MW nuclear PPA. 2025 Adjusted EBITDA guidance narrowed to $5.7–$5.9 billion; 2026 guidance set at $6.8–$7.6 billion.
6 November 2025
··
BIYA Soars Over 100% on November 6, 2025: Baiya International’s Volatile Rally, Massive Volume, and What to Watch Ahead of 25‑for‑1 Share Consolidation Vote

BIYA Soars Over 100% on November 6, 2025: Baiya International’s Volatile Rally, Massive Volume, and What to Watch Ahead of 25‑for‑1 Share Consolidation Vote

Shares of Baiya International Group (NASDAQ: BIYA) surged over 100% in U.S. trading Thursday, with intraday volume topping 200 million shares. No new company press release or SEC filing appeared to explain the spike. The move followed a 149% after-hours jump Wednesday and comes ahead of a Nov. 28 shareholder vote on a 25-for-1 reverse split.
6 November 2025
·
Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics reported Q3 2025 revenue of $67.5 million, up 13% sequentially but below analyst expectations, and a net loss of $91.3 million, or $0.25 per share. Gross margin rose to 43%. Management reaffirmed full-year revenue guidance of $250–$300 million. Over 80 U.S. treatment centers are now active, and cash reserves totaled $307 million at quarter’s end.
6 November 2025
···
Novavax (NVAX) Raises 2025 Revenue Outlook After Q3 Beat; Sanofi Milestones Drive Guidance — November 6, 2025

Novavax (NVAX) Raises 2025 Revenue Outlook After Q3 Beat; Sanofi Milestones Drive Guidance — November 6, 2025

Novavax raised its FY2025 adjusted revenue outlook to $1.04–$1.06 billion after reporting Q3 revenue of $70 million, above estimates. The company posted a GAAP net loss of $202 million for the quarter, impacted by $126 million in non-cash charges tied to Maryland site consolidation and debt. Two $25 million milestone payments from Sanofi will be recognized in Q4. Cash stood at $778 million as of September 30.
6 November 2025
·····
DoorDash (DASH) plunges as 2026 spending plan eclipses Q3 beat — What to know today (Nov 6, 2025)

DoorDash (DASH) plunges as 2026 spending plan eclipses Q3 beat — What to know today (Nov 6, 2025)

DoorDash shares fell about 9% premarket after the company said it will boost 2026 spending by several hundred million dollars to accelerate a new global tech platform, overshadowing strong Q3 results. Revenue rose 27% to $3.45 billion and total orders climbed 21%, but EPS of $0.55 missed estimates. The Deliveroo acquisition closed Oct. 2. DoorDash’s $5 billion buyback remains unused.
6 November 2025
··
D‑Wave Quantum (QBTS) Q3 2025: Revenue Doubles to $3.7M, Record $836M Cash, Bookings Accelerate — What It Means for the Stock Today

D‑Wave Quantum (QBTS) Q3 2025: Revenue Doubles to $3.7M, Record $836M Cash, Bookings Accelerate — What It Means for the Stock Today

D‑Wave Quantum posted Q3 revenue of $3.7 million, doubling year over year, with bookings jumping to $2.4 million. The company ended the quarter with a record $836.2 million in cash, boosted by warrant exercises, while GAAP net loss widened to $140 million due to $121.9 million in non-cash charges. Shares traded near $31 intraday. Over $12 million in additional bookings closed after quarter-end.
6 November 2025
···
Arm Holdings (ARM) Beats Q2, Lifts Q3 Outlook on AI Momentum — What to Know Today (Nov. 6, 2025)

Arm Holdings (ARM) Beats Q2, Lifts Q3 Outlook on AI Momentum — What to Know Today (Nov. 6, 2025)

Arm reported fiscal Q2 revenue of $1.14 billion, up 34% year-over-year and above estimates, with non-GAAP EPS of $0.39. The company raised Q3 revenue guidance to about $1.225 billion, citing strong AI demand. Royalties climbed 21% to $620 million, licensing jumped 56% to $515 million. Major brokers raised price targets after results.
6 November 2025
····
e.l.f. Beauty (ELF) plunges as tariff hit and soft FY‑2026 outlook overshadow Rhode boost: what to know today (Nov. 6, 2025)

e.l.f. Beauty (ELF) plunges as tariff hit and soft FY‑2026 outlook overshadow Rhode boost: what to know today (Nov. 6, 2025)

e.l.f. Beauty shares plunged over 20% after the company forecast FY‑2026 revenue of $1.55–$1.57 billion and adjusted EPS of $2.80–$2.85, both missing analyst estimates. Tariff costs exceeding $50 million and 75% China sourcing pressured margins, which fell 165 basis points. Q2 net sales rose 14% to $343.9 million; adjusted EPS was $0.68. Piper Sandler and UBS downgraded the stock following the guidance.
6 November 2025
··
MMTec (MTC) soars 627% and then whipsaws pre‑market as Nasdaq delisting clock ticks — What to know today (Nov. 6, 2025)

MMTec (MTC) soars 627% and then whipsaws pre‑market as Nasdaq delisting clock ticks — What to know today (Nov. 6, 2025)

MMTec (NASDAQ: MTC) surged 627% on Nov. 5 before dropping 24% pre-market Nov. 6 amid heavy volatility. The moves follow a Nasdaq delisting notice over minimum bid price rules, with MMTec requesting a hearing to avoid suspension. As of 14:06 UTC, shares traded near $2.21. The company completed a 1-for-8 reverse split in December 2024.
6 November 2025
··
Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

Oscar Health reported Q3 revenue of $2.99 billion, up 23% year-over-year but below analyst estimates. The company posted a net loss of $137.5 million, or –$0.53 per share, beating EPS expectations. Medical loss ratio rose to 88.5%. Oscar exchanged $187.5 million of 2031 notes for about 23.3 million shares and reaffirmed its 2025 outlook.
6 November 2025
··
Celsius Holdings (CELH) Q3 2025: Revenue Jumps 173% to $725.1M; GAAP Loss on Distribution Charges as PepsiCo Partnership Deepens

Celsius Holdings (CELH) Q3 2025: Revenue Jumps 173% to $725.1M; GAAP Loss on Distribution Charges as PepsiCo Partnership Deepens

Celsius Holdings posted Q3 revenue of $725.1 million, up 173% year over year, with North America accounting for $702 million. GAAP diluted EPS fell to $(0.27) due to $246.7 million in distributor termination costs tied to the Alani Nu transition, while adjusted EPS reached $0.42. Gross margin rose to 51.3%. The company’s U.S. ready-to-drink energy portfolio captured a 20.8% dollar share.
6 November 2025
····
Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir (PLTR) adds two AI deals today—Stagwell marketing platform and Spain’s Valoriza—after blowout Q3: stock, guidance and what to watch (Nov. 6, 2025)

Palantir announced partnerships with Stagwell to develop an AI marketing platform and with Valoriza to modernize urban environmental services in Spain. The company reported Q3 revenue of $1.181 billion, up 63% year-over-year, and raised its FY25 revenue guidance to as much as $4.4 billion. Management disclosed 204 Q3 deals worth at least $1 million each. Financial terms of the Valoriza deal were not disclosed.
6 November 2025
····
Ford (F) Stock Surges on Earnings – Rally Faces EV & Recall Challenges

Ford (F) News Today — Nov. 6, 2025: Louisville plant pauses after UPS crash, Maverick 300T turns heads at SEMA, Farley questions Apple CarPlay Ultra; shares hover near $13

Ford halted production at its Louisville Assembly Plant after a UPS cargo jet crash killed at least 12 near the site; no Ford employees were hurt, and a partial crew is preparing for restart. UPS’ Worldport hub closure is delaying deliveries across the supply chain. At SEMA, Ford unveiled a 300-hp Maverick upgrade kit for 2026. Ford will phase out the 2.0-liter bi-turbo diesel for Ranger/Everest in Australia in 2026.
6 November 2025
·
Opendoor’s Meteoric 1600% Rally – Can the Real Estate Disruptor Keep Soaring or Will It Stumble Next?

Opendoor (OPEN) Q3 2025 Earnings Today: Robinhood Livestream Debut, What to Watch [Nov 6, 2025]

Opendoor Technologies will report Q3 2025 earnings after market close today and replace its usual call with a “Financial Open House” livestream on Robinhood and its investor site at 5:00 p.m. ET. Analysts expect sharp year-over-year revenue declines and continued losses, with attention on Q4 guidance. Kaz Nejatian took over as CEO in September, joined by returning co-founders on the board. A $39 million legal settlement awaits court approval.
6 November 2025
···
Pinterest Stock Plunges 18% on Earnings Miss – Can AI and Record Users Fuel a Rebound?

Pinterest (PINS) plunges as holiday‑quarter outlook disappoints; ARK Invest buys the dip — what to know today (Nov. 6, 2025)

Pinterest shares extended losses Thursday, trading in the mid-$20s after weak holiday-quarter guidance overshadowed record Q3 user growth and a 17% revenue jump to $1.049 billion. The stock fell about 20% Wednesday and continued sliding as analysts cut ratings and targets, citing ad market softness and tariff-related headwinds. Q4 revenue is projected at $1.313–$1.338 billion, below Wall Street expectations.
6 November 2025
··
Snap (SNAP) Surges on $400M Perplexity AI Tie‑Up; Fresh Analyst Target, Q3 Beat & Buyback — All the Key Updates for November 6, 2025

Snap (SNAP) Surges on $400M Perplexity AI Tie‑Up; Fresh Analyst Target, Q3 Beat & Buyback — All the Key Updates for November 6, 2025

Snap signed a $400 million deal with Perplexity AI to integrate its answer engine into Snapchat’s chat, with rollout set for early 2026. Shares surged double digits pre-market after the news. Snap reported Q3 revenue of $1.507 billion, 477 million daily active users, and a narrowed net loss of $104 million. BMO Capital raised its price target to $13, citing the Perplexity partnership and Q3 results.
6 November 2025
···
Rivian’s Wild 2025 Ride: Stock Price Update, Q3 Surprises, EV Rivalry & Future Forecasts

Rivian (RIVN) Tops Q3: $1.56B Revenue, $416M Software & New ‘Mind Robotics’ Spinoff — Nov. 6, 2025

Rivian reported Q3 revenue of $1.56 billion, up 78% year-over-year, and its first positive consolidated gross profit of $24 million. Software and services revenue surged to $416 million, boosted by the Volkswagen partnership. The company launched Mind Robotics, an industrial AI spinoff, with over $110 million in outside funding. Shares held most of Wednesday’s 23% rally, trading slightly lower pre-market.
6 November 2025
··
Duolingo (DUOL) Plunges After Soft Q4 Bookings Outlook Despite Q3 Beat; Daily Users Top 50 Million — What to Know Today (Nov. 6, 2025)

Duolingo (DUOL) Plunges After Soft Q4 Bookings Outlook Despite Q3 Beat; Daily Users Top 50 Million — What to Know Today (Nov. 6, 2025)

Duolingo reported Q3 revenue of $271.7 million, topping estimates and raising FY25 guidance, but issued a Q4 bookings outlook of $329.5–$335.5 million, below consensus. Shares fell about 20% after hours and slid as much as 26% premarket. Daily active users hit 50 million, up 36% year over year. Q3 gross margin reached 72.5%, with the CEO citing profitable AI features.
6 November 2025
··
1 … 1,245 1,246 1,247 1,248 1,249 … 1,371

Stock Market Today

  • Smallcap Stocks Rally Up to 72% Despite Nifty Drop in March
    April 4, 2026, 2:49 AM EDT. In March, while the Nifty index fell approximately 11%, certain smallcap stocks surged as much as 72%. One notable stock in this group rose 24.3%. It operates in manufacturing sugar, industrial alcohol (ethanol), and power co-generation. The company strategically focuses on ethanol production, aligning with biofuel mandates aimed at reducing fossil fuel use. These gains underscore the divergent performance within Indian equities amid broader market volatility. Investors might consider reviewing their portfolios for such resilient smallcap opportunities.
Go toTop